Website profile

Australian Financial Review

The Australian Financial Review reports the latest news from business, finance, investment and politics, updated in real time. It has a reputation for independent, award-winning journalism and is essential reading for the business and investor community.

  • 950articles · 30d
  • 1+ hour agolatest article
  • Aug 15, 2026earliest in window
  • 0%with images
  • 95avg words
articles per day
Categories
  • Economy, Business & Finance 498
  • Finance & Business 428
  • News 371
  • Politics 187
  • Politics2 149
  • Finance 113
  • Business & Industrial 97
  • Real Estate 63

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Australian Financial Review
afr.com > street-talk > three-s-a-party-medtech-bcal-woos-genetic-signatures-sonic-s-microba-20260909-p60vu5

Three’s a party! Medtech BCal woos Genetic Signatures, Sonic’s Microba

4+ day, 17+ hour ago   (110+ words) AFR If you can’t beat ’em, join ’em. BCAL Diagnostics’ plans to nab fellow ASX-listed biotech Genetic Signatures hit the skids after revelations the target was already flirting with Sonic Healthcare-backed Microba Life Sciences. There’s an FDA approval in the…...

Australian Financial Review
afr.com > policy > health-and-education > how-an-australian-scientist-led-a-cancer-vaccine-breakthrough-20260820-p60pzj

How an Australian scientist led a cancer vaccine breakthrough

3+ week, 3+ day ago   (65+ words) AFR Georgina Long was in Lisbon when news broke that her decades of work developing therapies to fight skin cancer had hit the jackpot. It was 2am on Thursday morning in Portugal and the former Australian of the Year was bunkered…...

Australian Financial Review
afr.com > companies > healthcare-and-fitness > moderna-shares-nearly-triple-on-skin-cancer-vaccine-success-20260820-p60pxz

Moderna shares nearly triple on skin cancer vaccine success

3+ week, 4+ day ago   (64+ words) afr.com New York/London | Shares in US vaccine-maker Moderna nearly tripled after it reported successful trial results for an experimental skin cancer therapy. The experimental therapy, jointly developed with Merck, would be unprecedented in cancer treatment, providing a custom-made…...